Sign Up

ARTV

COM:ARTIVABIO

Artiva Biotherapeutics

  • Stock

USD

Last Close

10.88

22/11 21:00

Market Cap

105.10M

Beta: -

Volume Today

36.36K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.80M
-
1.27M
29.35%
855K
32.68%
average receivables
234K
-
496.50K
112.18%
1.14M
129.91%
book value per share
-5.05
-
-8.00
58.34%
-17.32
116.45%
capex per share
0.10
-
0.36
265.37%
0.35
2.78%
capex to depreciation
6.95
-
5.44
21.75%
1.44
73.57%
capex to operating cash flow
-0.11
-
-0.12
10.01%
-0.07
44.57%
capex to revenue
0.86
-
1.28
48.34%
0.10
92.38%
cash per share
9.15
-
5.83
36.29%
8.23
41.11%
days of inventory on hand
days payables outstanding
days sales outstanding
85.32
-
38.86
54.45%
19.16
50.70%
debt to assets
0.01
-
debt to equity
-0.02
-
dividend yield
earnings yield
-0.34
-
-0.28
18.71%
-0.25
10.84%
enterprise value
51.82M
-
127.92M
146.86%
75.66M
40.85%
enterprise value over ebitda
-0.72
-
-2.18
201.16%
-2.66
22.18%
ev to operating cash flow
-3.39
-
-2.52
25.67%
-1.60
36.61%
ev to sales
25.88
-
25.94
0.23%
2.26
91.29%
free cash flow per share
-0.97
-
-3.25
235.49%
-5.42
66.78%
free cash flow yield
-0.08
-
-0.27
235.49%
-0.45
66.78%
graham net net
-5.55
-
-9.72
75.19%
-20.19
107.79%
graham number
21.55
-
24.45
13.45%
33.97
38.92%
income quality
0.21
-
0.86
305.78%
1.65
91.01%
intangibles to total assets
0
-
0
0
interest coverage
interest debt per share
0.10
-
inventory turnover
invested capital
147.06M
-
106.66M
27.47%
92.24M
13.52%
market cap
211.00M
-
211.00M
0%
112.25M
46.80%
net current asset value
-96.50M
-
-169.07M
75.21%
-187.31M
10.78%
net debt to ebitda
2.22
-
1.42
36.33%
1.29
9.03%
net income per share
-4.08
-
-3.32
18.71%
-2.96
10.84%
operating cash flow per share
-0.87
-
-2.89
232.13%
-5.07
75.40%
payables turnover
receivables turnover
4.28
-
9.39
119.56%
19.05
102.84%
research and ddevelopement to revenue
21.18
-
8.92
57.89%
1.50
83.18%
return on tangible assets
-0.42
-
-0.44
3.82%
-0.26
39.96%
revenue per share
0.11
-
0.28
146.30%
3.58
1,176.68%
roe
0.81
-
0.41
48.66%
0.17
58.81%
roic
0.45
-
0.43
6.16%
0.19
55.41%
sales general and administrative to revenue
6.43
-
4.21
34.43%
0.42
90.14%
shareholders equity per share
-5.05
-
-8.00
58.34%
-17.32
116.45%
stock based compensation to revenue
2.15
-
1.34
37.94%
0.21
84.23%
tangible asset value
-88.86M
-
-140.70M
58.34%
-162.01M
15.15%
tangible book value per share
-5.05
-
-8.00
58.34%
-17.32
116.45%
working capital
142.98M
-
79.05M
44.71%
67.59M
14.49%

All numbers in USD (except ratios and percentages)